CoChat

Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.

Ferrer, Ricard, Artigas, Antonio, Suarez, David, Palencia, Eduardo, Levy, Mitchell M., Arenzana, Angel, Pérez, Xose Luis, Sirvent, Josep-Maria · 2009 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Rationale: Several Surviving Sepsis Campaign Guidelines recommendations are reevaluated. Objectives: To analyze the effectiveness of treatments recommended in the sepsis guidelines. Methods: In a prospective observational study, we studied all adult patients with severe sepsis from 77 intensive care units. We recorded compliance with four therapeutic goals (central venous pressure 8 mm Hg or greater for persistent hypotension despite fluid resuscitation and/or lactate greater than 36 mg/dl, central venous oxygen saturation 70% or greater for persistent hypotension despite fluid resuscitation and/or lactate greater than 36 mg/dl, blood glucose greater than or equal to the lower limit of normal but less than 150 mg/dl, and inspiratory plateau pressure less than 30 cm H2O for mechanically ventilated patients) and four treatments (early broad-spectrum antibiotics, fluid challenge in the event of hypotension and/or lactate greater than 36 mg/dl, low-dose steroids for septic shock, drotrecogin alfa [activated] for multiorgan failure). The primary outcome measure was hospital mortality. The effectiveness of each treatment was estimated using propensity scores. Measurements and Main Results: Of 2,796 patients, 41.6% died before hospital discharge. Treatments associated with lower hospital mortality were early broad-spectrum antibiotic treatment (treatment within 1 hour vs. no treatment within first 6 hours of diagnosis; odds ratio, 0.67; 95% confidence interval, 0.50–0.90; P = 0.008) and drotrecogin alfa (activated) (odds ratio, 0.59; 95% confidence interval, 0.41–0.84; P = 0.004). Fluid challenge and low-dose steroids showed no benefits. Conclusions: In severe sepsis, early administration of broad-spectrum antibiotics in all patients and administration of drotrecogin alfa (activated) in the most severe patients reduce mortality.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.200812-1912oc

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. 2006, Crit Care Med, 34, A108
  2. 2008, JAMA, 300, 1762

Cited by

See all 498

Metadata

Authors
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
  • Hospital Universitario Infanta Leonor (ES)
  • Brown University (US)
  • Servicio de Medicina Intensiva, Hospital Virgen de la Macarena, Sevilla
  • Servicio de Medicina Intensiva, Hospital Universitari de Bellvitge, Hospitalet de Llobregat; and
  • Servicio de Medicina Intensiva, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2009-11-01
Volume
180
Issue
9
Pages
861-866
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2109728419
Cited by
433
References
41
Citations by year
2026: 9 · 2025: 15 · 2024: 13 · 2023: 20 · 2022: 15 · 2021: 38 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 35 · 2016: 29 · 2015: 28 · 2014: 43 · 2013: 28 · 2012: 33
FWCI
21.26
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
severe sepsis, Surviving Sepsis Campaign guidelines, guideline adherence, drotrecogin alfa, septic shock, fluid challenge, low-dose corticosteroids, mechanical ventilation, central venous pressure, lactate, in-hospital mortality, propensity score matching
MeSH terms
Adrenal Cortex Hormones, Aged, Anti-Infective Agents, Anti-Bacterial Agents, Female, Fluid Therapy, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Protein C, Recombinant Proteins, Cohort Studies, Odds Ratio, Survival Analysis, Treatment Outcome, Hospital Mortality, Sepsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. https://app.cochat.ai/papers/10.1164/rccm.200812-1912oc
The paper
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009). Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200812-1912oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.